About simoctocog alfa
Recombinant human coagulation factor VIII
Used for
- Treatment and prevention of bleeding in haemophilia A
- Bleeding control during surgery in haemophilia A
Usual adult dose
Individualised by bleed severity, treatment goal, and measured factor VIII levels; given intravenously.
Usual dose in children
Individualised by body weight, bleed severity, and measured factor VIII levels; given intravenously.
Common side effects
- Headache
- Injection-site reactions
- Fever
- Development of factor VIII inhibitors
Important warnings
- Factor VIII inhibitors can reduce treatment effectiveness.
- Severe allergic reactions may occur.
- Dose is guided by factor VIII levels and clinical response.
- Not for von Willebrand disease or haemophilia B.
Pregnancy
Limited human data; use when needed to control bleeding, under specialist care.
Breastfeeding
Limited data; use when needed, under specialist care.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.